Rab5 knockdown reduces the production of exosomes and promotes macrophage polarization toward an antitumor phenotype, suggesting that Rab5 could serve as a potential therapeutic target for triple-negative breast cancer [35]. This evidence concerns the gene RAB5A and triple-negative breast carcinoma.